Fidaxomicin is a macrolide antibiotic used to treat Clostridioides difficile-associated diarrhea by inhibiting bacterial RNA polymerase. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dificid, Dificlir, Lipiarmicin and Difimicin. Its PubChem CID is 10034073.
Fidaxomicin
| CAS No | 873857-62-6 |
|---|---|
| Molecular Formula | C52H74Cl2O18 |
| Molecular Weight | 1058.99 g/mol |
| Synonyms | [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Fidaxomicin is a macrolide antibiotic used to treat Clostridioides difficile-associated diarrhea by inhibiting bacterial RNA polymerase. It is grouped under the following drug class(es): Macrolides.
The listed CAS number is 873857-62-6.
The listed molecular formula is C52H74Cl2O18.
The listed molecular weight is 1058.99 g/mol.
[(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate.
The source lists Dificid, Dificlir, Lipiarmicin and Difimicin.